Thus, the increase in ATG7 in our NASH patients is contradictory to the few existing previous references, although it could be due to an attempt by the liver to repair liver damage through ATG7-mediated autophagy, which has been shown to eliminate excess lipids by degradation [30]. This evidence concerns the gene ATG7 and metabolic dysfunction-associated steatohepatitis.